Investigation to see if cervical spine mobilisation can influence Cervicobrachial Syndrome
ISRCTN | ISRCTN87397856 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN87397856 |
Secondary identifying numbers | N0191187010 |
- Submission date
- 28/09/2007
- Registration date
- 28/09/2007
- Last edited
- 17/10/2016
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Ms Emma Salt
Scientific
Scientific
Musculoskeletal Physiotherapy Lead
Queen's Hospital
Belvedere Road
Burton upon Trent
DE13 0RB
United Kingdom
Study information
Study design | Pilot study using a randomised controlled design, with the assessor masked to allocation |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Treatment |
Participant information sheet | Not available in web format, please use the contact details below to request a patient information sheet |
Scientific title | Investigation to see if cervical spine mobilisation can influence Cervicobrachial Syndrome |
Study objectives | 1. To investigate whether a self-management protocol with lateral glide mobilisation is more advantageous than a self-management protocol in isolation for subjects with cervicobrachial syndrome. 2. To establish whether subjects with symptoms of parasthesia, numbness and or weakness in their affected arm in addition to their pain have a different outcome from subjects with pain alone. 3. To determine whether subjects preference is linked with outcome. 4. To determine feasibility and enable thorough planning for a phase III trial. |
Ethics approval(s) | Added 21/09/09: South Staffordshire Local Research Ethics Committee |
Health condition(s) or problem(s) studied | Musculoskeletal Diseases: Cervicobrachial syndrome |
Intervention | Subjects will receive either lateral glide mobilisations and a self-management programme (Intervention group) or self-management alone (Control group) for the management of cervicobrachial syndrome. Due to the nature of the intervention, it will not be possible to mask subjects and treating physiotherapists to allocation. Assessment will occur at consent, and 6 weeks after initiation of treatment. |
Intervention type | Other |
Primary outcome measure | Added 21/09/09: Visual analogue scale for pain |
Secondary outcome measures | Added 21/09/09: 1. Neck and Upper Limb Index (NULI) 2. SF36 (RAND) 3. Global Rating of Change Score (GROC) |
Overall study start date | 01/02/2007 |
Completion date | 01/06/2008 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Not Specified |
Sex | Not Specified |
Target number of participants | Added 21/09/09: 18 |
Key inclusion criteria | This study includes patients with any symptoms radiating from the neck to upper limb. Added 21/09/09: 1. Patients with pain that had started in the neck and spread to one arm (below level of shoulder joint) in a dermatological distribution and been present for more than two months 2. There were no known systemic rheumatological (e.g. Rheumatoid Arthritis RA or Ankylosing Spondylitis AS) or neurological disorders (e.g. Multiple Sclerosis MS, Parkinson's Disease PD) 3. Not involved with any litigation issues regarding neck and arm pain and no symptoms of myelopathy or sinister pathology 4. No previous fractures to the neck or thoracic spine |
Key exclusion criteria | Does not meet inclusion criteria |
Date of first enrolment | 01/02/2007 |
Date of final enrolment | 01/06/2008 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Musculoskeletal Physiotherapy Lead
Burton upon Trent
DE13 0RB
United Kingdom
DE13 0RB
United Kingdom
Sponsor information
Record Provided by the NHSTCT Register - 2007 Update - Department of Health (UK)
Not defined
Not defined
The Department of Health, Richmond House, 79 Whitehall
London
SW1A 2NL
United Kingdom
Phone | +44 (0)20 7307 2622 |
---|---|
dhmail@doh.gsi.org.uk | |
Website | http://www.dh.gov.uk/Home/fs/en |
Funders
Funder type
Government
Burton Hospitals NHS Trust (UK), Own Account NHS R&D Support Funding
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Editorial Notes
17/10/2016: No publications found in PubMed, verifying study status with principal investigator.